Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy
We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full...
Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?
We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full...
Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely
We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full...
Is Bob’s Discount Furniture (BOBS) a Good Retail Stock to Buy for Long-Term Growth?
We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full...
Here’s What Makes Intellia Therapeutics (NTLA) a High-Risk, High-Reward Stock for Long-Term Investors
We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full...
Here’s What Makes Red Cat Holdings (RCAT) a Speculative Long-Term Buy in the Drone Market
We recently published our article Top 10 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. In this article, we...
Could CRISPR Therapeutics (CRSP) Be One of the Best Long-Term Biotech Stocks in Gene Editing?
We recently published our article Top 10 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. In this article, we...
Is Lyft (LYFT) a Good Stock to Buy as the Rideshare Market Keeps Growing?
We recently published our article Top 10 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. In this article, we...
Could Sarepta Therapeutics (SRPT) Be a High-Risk Comeback Stock Investors Should Watch?
We recently published our article Top 10 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. In this article, we...
Is Globant (GLOB) a Good AI Consulting Stock to Buy for Long-Term Growth?
We recently published our article Top 10 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. In this article, we...